Neurocrine Biosciences, Inc. · NASDAQ:NBIX
The Vanguard Group reported a 10.15% stake in Neurocrine Biosciences, Inc. (Schedule 13G/A)
Event Feb 28, 2025 · Filed Mar 6, 2025
The Vanguard Group reported a 10.15% stake in Neurocrine Biosciences, Inc., 10,129,687 shares, as a passive investor on Feb 28, 2025. Filed Mar 6, 2025 (Schedule 13G/A).
- Stake
- 10.15%
- Shares
- 10,129,687
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 10.15% | 10,129,687 |
Source
Related
- Neurocrine Biosciences, Inc.
- The Vanguard Group
- Neurocrine Biosciences, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Oct 15, 2026
- Form 4 · Boyer David W. · Sep 15, 2026
- Form 4 · Abernethy Matt · Sep 15, 2026
- Form 4 · Gano Kyle · Sep 15, 2026
- Form 4 · Onyia Jude · Sep 15, 2026